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Abstract
Scant literature exists regarding health effects of fine
particulate matter (PM2.5) pollution at or below
national standards. This study examined the
relationship between PM2.5 and acute care use and
costs in Honolulu where PM2.5 is low. Single and
distributed lag over-dispersed Poisson models were
used
to
examine
hospitalizations/emergency
department (ED) visits associated with cumulative
PM2.5 exposure over the current day and seven
previous days (lags 0-7) in 2011. A 10-µg/m3 increase
in cumulative PM2.5 concentration was associated with
a 32% increase in respiratory admissions (RR=1.32,
p=0.001) costing $486,908 and a 24% decrease in
respiratory admissions in the comparison group
(RR=0.76, p<0.001). ED visits increased by 12% at
lag day 0 for respiratory outcomes (RR=1.12, p=0.03)
and cumulatively with increased respiratory visits by
49% (RR=1.49) and increased combined respiratory
and cardiovascular issues by 20% (RR=1.20; p<0.01
for both) costing $117,856. Additional research is
needed on health effects within pollution lower levels.

1. Introduction
Particulate matter is generated from fires, road
dust, electrical power plants, industrial processes, and
vehicles and contributes to air pollution as an ongoing
environmental threat to health [1]. Most concerning are
very small particles, less than 2.5 micrometers (µ) in
width, known as fine particulate matter (PM2.5),
because they are small enough that they may be
inhaled into the cardiopulmonary system. Once
inhaled, they may irritate and cause inflammation in
the lungs leading to asthma attacks, bronchitis, and
decreased lung function [2], as well as the blood
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vessels around the heart, increasing the risk of heart
attack, stroke, arrhythmias, and heart failure,
particularly in elderly patients or those with preexisting medical conditions [3]. These effects were
noted in landmark studies such as the Harvard Six
Cities study and the American Cancer Society study
that demonstrated that higher levels of PM2.5 are a
causative factor for increased cardiopulmonary disease
and mortality risk [4-5].
Further research has demonstrated that exposure to
PM2.5 is a well-established concern at annual averages
above the set current standard (above 12 µ/m3) with
increases of 10 µ/m3 associated with increased
emergency department (ED) visits, hospital
admissions, and deaths due to respiratory and
cardiovascular adverse health effects [6-10]. Further,
increased hospitalizations for mental health [11] as
well as increased hospitalizations and mortality due to
stroke have also been linked to elevated levels of PM2.5
[12]. Several studies have also investigated lag times in
relation to health outcomes due to exposure to PM2.5
above current acceptable standards with lag periods
varying from 2-7 days [7-10]. However, with the
exception of a study that showed an inverse association
of chronic obstructive pulmonary disease (COPD)
exacerbations with a 7-day lag [13] and a study that
showed association with arrhythmias, atrial fibrillation,
and pulmonary embolism with lags up to four days
[14], no other studies have examined the association
between current acceptable PM2.5 levels with a lag
period relative to health outcomes. In terms of health
outcomes, the majority of studies have utilized daily
counts of hospital admissions or ED visits as measured
by International Classification of Diseases 9th revision
(ICD-9) or 10th revision (ICD-10) codes. Other
methods to determine health outcomes in previous
studies included annual patient interviews, Medicare
claims counts, disease management groups within a
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medical practice, and mortality counts. A few have
utilized population-based or national inpatient
registries.
Based on evidence of harm from exposure to
higher levels of PM2.5, the World Health Organization
(WHO) set criteria for acceptable levels of ambient air
pollution and defined that PM2.5 should remain below
an average of 10 µ/m3 annually and below 25 µ/m3
over a 24-hour period [15]. In 2012, the United States
(US) Environmental Protection Agency (EPA) also
strengthened the health-based standard for PM2.5 to an
annual level of less than 12 µ/m3 (previously 15 µ/m3)
and kept the current 24-hour mean at less than 35 µ/m3
[16]. The EPA reported there was a 42% decrease in
the national average PM2.5 from 2000 to 2016, with
levels well within the more stringent standard in recent
years [17].
Only a few studies have examined the impact of
PM2.5 exposure at levels lower than the current US
EPA standards (below 12 µ/m3), but these also indicate
adverse health effects, including increases in hospital
admissions for all causes, cardiovascular and
respiratory diseases, and mortality [18-20]. These
studies were limited to a subset of the total population
(e.g., Medicare beneficiaries) and studied aggregated
impact rather than examining the effects of daily
variation in air quality. Advancing knowledge of the
effects of pollution at levels that meet current standards
is essential to informing discussions about the impact
of making additional changes to air quality standards
and related polices such as vehicle emissions.
Therefore, the objective of our study is to examine the
relationship between daily PM2.5 and acute care
admissions, with cumulative lag effects up to seven
days, across the population in an urban area (Honolulu)
that has relatively low levels of this pollutant. We also
aimed to explore the costs of these effects.
The average annual exposure of the general public
to PM2.5 in Hawaii has remained below 12 µ/m3 as well
as below annual averages in the US [21], and the
sources of air pollution vary by region within the state.
In addition to vehicle and industrial emissions from the
urban island of Oahu, volcanic smog (“vog”) from the
active Kilauea volcano is a key source of PM2.5 on the
Big Island based on wind patterns, and prior to 2017,
sugar cane burning during the pre-harvest season added
pollution on the island of Maui. Hawaii Health
Information Corporation (HHIC) maintains a robust
data set encompassing state-wide, population-wide
acute care health information. Previous studies using
this data set indicate it holds promise for other air
quality research. One study examined the association
between sugar cane burning and acute respiratory
illness in 2011 in a subset of patients on Maui [22] and
another examined the association of pollution from

volcanic emissions on ED visits for pulmonary and
cardiovascular conditions and used ED visits for
fractures as a comparison group expected to be
unrelated to pollution [23]. Thus, Hawaii is an ideal
location to study associations between relatively low
levels of PM2.5 and health outcomes.

2. Methods
Honolulu County, comprising the island of Oahu,
was the selected region of Hawaii as it has more
typical pollution sources and the largest population
relative to other areas in the state. The three hospitals
outside of the Honolulu area where air quality sensors
are located were excluded from the analyses. Data
from patients with a home address outside of Hawaii
were also excluded to minimize impact of variations in
tourist volume on acute care episode frequency.

2.1. Exposure
PM2.5 data for 2011 were obtained from the US
EPA’s Air Quality System database based on the four
monitors located in Honolulu County that collected
local daily PM2.5 conditions (located at downtown
Honolulu, Kapolei, Sand Island, and Pearl City). The
Hawaii Department of Health (DOH) continuously
monitors air quality at each of these sites. The hourly
averages are recorded, reviewed, validated, and if
needed, revised due to equipment or other technical
problems [24-26]. The DOH reports these validated
hourly measures to the EPA, and the EPA calculates
the daily mean PM2.5 concentrations from the hourly
data. Daily PM2.5 concentrations from all four monitors
were averaged for the current study.

2.2. Main Outcome Measures
HHIC collects, cleans, and verifies detailed
patient-level discharge data from all non-federal
hospitals for all payers across the state of Hawaii. The
HHIC dataset contains clinically relevant information
used for billing and other administrative purposes. It is
not an electronic medical record. The 2011 HHIC
dataset of all ED visits (N=110,283) and all hospital
admissions (N=74,600) was used to obtain population
counts of daily acute care use by reason for admission.
These counts include repeat use by the same patient
(i.e., these counts are the number of episodes of acute
care, not number of unique patients). Reason for each
admission was based on All Patient Refined Diagnosis
Related Groups (APR DRG) codes, a classification
system that describes each admission based on a
clinical grouping that can be further described by
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severity of illness [27]. We obtained the daily counts of
acute care episodes for respiratory and cardiovascular
clinical groups, which have previously been found to
be associated with high levels of PM2.5, and for a
comparison group of clinical conditions not expected
to be associated with this pollutant (Appendix 1).
Because these methods cover all acute care episodes
for the population of Honolulu, there was no need to
control for age, gender, or other demographic
variables.

2.3. Data Analysis
Descriptive statistics were used to characterize
daily 2011 PM2.5 concentration level and hospital/ED
admission outcomes in Honolulu County. Single lag
and distributed lag over-dispersed Poisson regression
models were used to examine the relative rate (RR) of
hospitalizations/ED visits (respiratory, cardiovascular,
combined respiratory and cardiovascular, and a
comparison group of admissions not expected to be
related to increases in acute care use) associated with
cumulative exposure over the current day and the
seven previous days (lags 0-7). While single lag
models assume that the effect in PM2.5 is over a single
day determined by the lag ℓ, distributed lag models
assume that the effect on a given day is spread out over
K previous days and typically have the form:
!

log 𝜇! = 𝛼 +

𝛽ℓ 𝑥!!ℓ + 𝐷𝑂𝑊 + 𝑠 𝑡𝑖𝑚𝑒, 𝑑𝑓
ℓ!!

where 𝛼 is the intercept; K is the maximum days of
lag; 𝛽 represents the regression coefficient for PM2.5;
𝑥! represents PM2.5 concentration levels at day t; DOW
is a dummy variable for day of the week; and s is the
smoothing spline function for nonlinear variables. In
these analyses, models were adjusted for day of the
week and smooth functions of calendar time (natural
cubic splines) with one degree of freedom. The degrees
of freedom (df) were selected according to the
minimum value of the Akaike information criterion
(AIC) for the Poisson model [28], with smaller AIC
values indicating the preferred model. According to
Peng and Dominici, choosing a large df will remove
bias but will also remove most of the temporal
variation in the residuals and thus lead to a large
variance of the estimated air pollution coefficient [29].
Further, choosing a small df may lead to bias but also
provides a more precise estimate of the air pollution
coefficient [29]. Analyses were conducted using
hospital and ED admissions, separately. Statistical
significance was taken at the 0.05 level. Mean
hospitalization and ED costs were estimated using the
Centers for Medicare and Medicaid Services (CMS)
cost-to-charge ratio (CCR) for fiscal year 2011, which

was 0.379 for urban Hawaii [30]. Descriptive statistics
were performed using SAS version 9.4 (SAS Institute
Inc., Cary, NC) and all other analyses were conducted
using the ‘dlnm’ package in R version 3.4.0.

3. Results
Table 1 displays descriptive statistics for 2011
daily PM2.5 and daily hospitalizations/ED visits in
Honolulu County. The average daily PM2.5
concentration in Honolulu County was 5.71 µg/m3
(interquartile range [IQR], 3.85-7.15 µg/m3) or average
of 45.68 µg/m3 cumulative over the 8-day period of
interest (0-7 days). For hospitalizations, the daily mean
respiratory and cardiovascular admissions were 15.44
(123.52 eight-day cumulative mean) ± 4.60 and 14.80
(118.4 eight-day cumulative mean) ± 3.93,
respectively. For ED visits, the daily mean respiratory
and
cardiovascular
admissions
were
each
approximately 25, or 200 for the eight-day cumulative
mean (Table 1).
Table 1. Descriptive statistics for 2011 daily PM2.5
and daily admissions in Honolulu County
Mean
Med
MinVariable
Max
(Q25, Q75)
± SD
5.71
5.36
0.403
PM2.5 (µ/m )
26.43
± 2.70 (3.85, 7.15)
Hospitalizations
15.44
Respiratory
15 (12, 18)
6-36
admissions
± 4.60
14.80
CV admissions
15 (12, 18)
5-25
± 3.93
Combined
30.24
respiratory and
30 (25, 34)
13-50
± 6.41
CV admissions
Admissions not
155.69
expected to be
166
related to
80-220
±
(122, 185)
increases in
34.96
acute care use
204.38
214
All admissions
114-275
±
(163, 238)
40.83
ED Visits
25.21
Respiratory
25 (21, 28)
14-43
admissions
± 5.31
24.35
CV admissions
24 (22, 27)
13-35
± 4.09
Combined
49.56
respiratory and
49 (45, 54)
34-75
± 6.96
CV admissions
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Admissions not
expected to be
related to
increases in
acute care use

195.34
±
14.31

195
(185, 205)

153236

302.15
302
251±
(289, 315)
368
19.96
CV=Cardiovascular; SD=Standard deviation;
Med=Median; Q25=25th percentile; Q75=75th
percentile; Min=Minimum; Max=Maximum;

Admissions not
expected to be related
0.96
to increases in acute
(0.93-1.01)
care use
CV=Cardiovascular; RR= Relative rate; 95% CI: 95%
Confidence interval; *p<0.01

All admissions

The RR and 95% confidence intervals (CIs) for the
increase/decrease in daily admission rates per 10µg/m3 increase in PM2.5 concentration for single lags of
0, 1, 2, 3, 4, 5, 6, and 7 days (data not shown) and the
distributed lag models for lags 0 through 7 for all
outcomes were generated. The single lag model
estimates the effect of exposure on one day only,
lagged by 0, 1, 2, 3, 4, 5, 6, or 7 days, while the
cumulative estimate from the distributed lag model
represents the effect of eight days of exposure (lag 0
through 7 days) [7]. The cumulative effects of PM2.5 on
daily admissions over 7 days of lag for all outcomes
are displayed in Table 2.
Table 2. Cumulative effects of a 10-µ/m3 increase in
PM2.5 on daily admissions in Honolulu County over
seven days of lag using distributed lag overdispersed Poisson regression modeling
RR
Variable
(95% CI)
Hospitalizations
Respiratory admissions

1.32
(1.11-1.56)*

CV admissions

0.92
(0.78-1.09)

Combined respiratory
and CV admissions

1.11
(0.99-1.24)

Admissions not
expected to be related
to increases in acute
care use
ED Visits

0.76
(0.70-0.82)*

Respiratory admissions

1.49
(1.32-1.67)*

CV admissions

0.95
(0.86-1.06)

Combined respiratory
and CV admissions

1.20
(1.10-1.30)*

3.1. Hospitalizations
There were no statistically significant single lag
estimates for all outcomes, with the exception of the
comparison group of admissions not expected to be
related to increases in acute care use (data not shown).
Specifically, we found evidence of negative
associations between day-to-day variation in PM2.5
concentration and the control outcome at lag 2 (data
not shown; RR=0.96, 95% CI=0.92-1.00, p=0.04), lag
3 (data not shown; RR=0.95, 95% CI=0.91-0.99,
p=0.01), and lag 4 (data not shown; RR=0.96, 95%
CI=0.92-0.99, p=0.02). Distributed lag model results
demonstrated statistically significant 8-day cumulative
effects for respiratory admissions and the comparison
group admissions. Specifically, there was a 32%
increase in respiratory hospital admissions in Honolulu
County associated with a 10-µg/m3 increase in PM2.5
over seven days of lag (Table 2; RR=1.32, 95%
CI=1.11-1.56, p=0.001). There was a 24% decrease in
admissions not expected to be related to increases in
acute care use associated with a 10-µg/m3 increase in
PM2.5 over seven days of lag (Table 2; RR=0.76, 95%
CI=0.70-0.82, p<0.001).

3.2. ED Visits
With the exception of the control outcome, there
was at least one exposure lag demonstrating statistical
significance for all outcomes. The largest effect was
found at lag 0 (same-day) for respiratory ED visits
(data not shown; RR=1.12, 95% CI=1.01-1.23,
p=0.03). Distributed lag estimates indicated
statistically significant 8-day cumulative effects for
respiratory visits as well as combined respiratory and
cardiovascular visits. Specifically, there was a 49%
increase in respiratory ED visits in Honolulu county
associated with a 10-µg/m3 increase in PM2.5 over
seven days of lag (Table 2; RR=1.49, 95% CI=1.321.67, p<0.001). There was a 20% increase in combined
respiratory and cardiovascular ED visits associated
with a 10-µg/m3 increase in PM2.5 over seven days of
lag (Table 2; RR=1.20, 95% CI=1.10-1.30, p<0.001).

3.3. Cost estimates
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Table 3 shows the mean cost estimate for each
category of hospitalization and ED visit. Using these
estimates, each 10-µg/m3 increase in PM2.5 over the 8day cumulative period of interest is associated with an
increase of 39.5 respiratory hospitalizations at a cost of
$486,908 and a decrease of 299 hospitalizations
unexpected to be related to air pollution at a cost of
$3,772,418. Each 10-µg/m3 increase in PM2.5 over the
8-day cumulative period of interest is associated with
an increase of 79.3 ED visits for respiratory or
cardiovascular conditions at a cost of $117,856.
Table 3. Descriptive statistics of cost (in US $)
estimated using the CMS cost-to charge ratio
(CCR) method for hospitalizations and ED visits in
Honolulu County
Mean
Med
MinVariable
(Q25, Q75)
Max
±SD
Hospitalizations
Respiratory
admissions

12,319
±15,814

7680
(4188, 14199)

0-249,
805

CV
admissions
Combined
respiratory
and CV
admissions
Admissions
not related
to increases
in acute
care use
ED Visits
Respiratory
Admissions

9,107
±11,642

6463
(3895, 10901)

0-478,
451

10,747
±14,020

7009
(4031, 12539)

0-478,
451

12,620
±25,911

6831
(2878, 13786)

0-1,169,
869

1,416
±1,287

1003
(561, 1797)

0-12,856

CV
admissions

1,560
±1,356

1222
(737, 1850)

0-37, 179

1,486
±1,323

1131
(633, 1821)

0-37, 179

1,332
±1,475

832
(450, 1673)

0-23, 114

Combined
respiratory
and CV
admissions
Admissions
not
expected to
be related
to increases
in acute
care use

CV=Cardiovascular; SD=Standard deviation;
Med=Median; Q25=25th percentile; Q75=75th
percentile; Min=Minimum; Max= Maximum

4. Discussion
At levels that meet the current more stringent EPA
standard, cumulative PM2.5 levels over an 8-day period
were significantly positively associated with an
increase in ED visits and hospital admissions for
respiratory conditions, but not cardiovascular
conditions. As expected, acute care use for the
comparison group of conditions did not increase with
air pollution. However, contrary to expectations,
hospital admissions for this comparison group
decreased significantly with cumulative increases in
PM2.5. It is possible that the lack of association with
acute care use for cardiovascular conditions and the
decrease in hospitalizations for comparison group
conditions is related to our methodology that counted
episodes of care and not individual patients, such that
each patient could be counted more than once with
multiple episodes of acute care. In addition, each acute
care episode is described only by the primary reason
for the episode, regardless of other co-existing
diagnoses. For example, a high percent of patients with
chronic respiratory disease also have overt
cardiovascular disease relative to those without
respiratory disease [31]. In our study, if the reason for
a patient’s acute care use is documented as respiratory,
it was counted only as a respiratory episode even if the
patient had co-morbid cardiovascular disease that
exacerbated the respiratory condition in response to
increases in pollution.
Research in Australia has found that
cardiovascular disease is only one of many co-morbid
conditions more common in those with COPD than
without [32]. They found that more than 90% of those
with COPD, which is one of the most common chronic
respiratory diseases, have at least one chronic
comorbid condition. These include conditions not
previously found to be associated with air quality. For
example, within age groups (age 45 to 64; age 65 and
older), those with COPD were significantly more likely
to report having arthritis and/or back problems
compared to those without COPD. To the extent that
the most complex and sensitive patients with multiple
chronic conditions are hospitalized for respiratory
problems, they decrease the count of patients who can
present in the emergency department or hospital for
other conditions. Thus, additional research is needed
using identifiers to determine these relationships at the
patient level.

Page 3765

Our research underscores the need for further
research on the effects of lower levels of PM2.5 and
other pollutants on health outcomes to inform policy
decisions. Fann and colleagues estimated the number
of PM2.5-attributable deaths avoided in the US due to
decreases in this pollutant from 1980 to 2010 following
regulatory action to improve outdoor air quality [33].
Based on previous research, they used two risk
coefficients (one log-linear and one non-linear) with
regard to the relationship between PM2.5 concentration
and health outcomes. They estimated that PM2.5
decreased by half and that deaths attributable to PM2.5
decreased by a third from 1980 to 2010. However, the
coefficient assumptions regarding the relationship
between lower levels of PM2.5 and health outcomes
need to be tested to improve the accuracy of these
estimates and inform discussions regarding the impact
of potential policy changes.
Our research also demonstrates the importance of
measuring cumulative effects when studying lower
levels of pollution. For example, we found no sameday or lagged-day effects of increases in PM2.5 on
hospital admissions for respiratory conditions.
However, we found a significant increase in respiratory
admissions with 8-day cumulative increases in PM2.5.
While our research used up to a 7-day lag, future
research should examine longer lag periods to further
explore the impact of variation in air quality at current
lower pollution levels. Additional research with data
covering multiple years is also needed to increase
statistical power. Finally, additional research is needed
that controls for variation in temperature and humidity.
Absent these controls, Hawaii is an ideal location for
such research given that there is little variation in
temperature or humidity year-round [34].
Our research demonstrates the value of
information systems that track health outcomes
population-wide. The all-payer, all-hospital system
based on routine administrative data maintained by
HHIC has a long history of use in tracking population
health indicators. Our current research shows its
potential for examining the relationship between these
health indicators and environmental variables.

5. Conclusion
Even at relatively low levels of pollution, there is a
significant association between increases in PM2.5 and
frequency of respiratory-related emergency department
visits and hospital admissions. Additional research is
needed on the impact of pollution at levels currently
well within national standards for air quality.

6. Appendices
Appendix 1. All Patient Refined Diagnosis Related
Group (APR DRG) codes queried
Type of
APR DRG codes
admissions
Respiratory
130-131,133-134, 137admissions
144
Cardiovascular
admissions

Admissions
not expected
to be related to
increases in
acute care use
(comparison
group)

190, 193-194, 196-199,
201, 203-204, 207
Cardiology (200, 205206); Cardiovascular
surgery (167, 169, 170171, 173-177, 180);
Dental (114);
Dermatology (380-381,
384-385);
Endocrinology (420425); ENT surgery (08993, 095, 097-098);
Gastroenterology (241249, 251-254, 279-280,
282-284); General
medicine (812-813, 816,
841-844, 862, 930);
General surgery (004005, 120-121, 135, 220229, 260-264, 361-364,
401, 403-405, 484, 650651, 680-681, 710-711,
721-722, 740, 791, 850,
911-912, 950-952);
Gynecological surgery
(510-514, 517-519, 545)
Gynecology (531-532);
Hematology (660-661,
663); Infectious disease
(049-051, 344, 383, 720,
724, 890, 892-894);
Neonatology (580, 583,
588-589, 591, 593, 603,
608-609, 611, 613-614,
621, 623, 625-626, 630631, 633, 636, 639-640)
Nephrology (460, 462463, 466, 468);
Neurological surgery
(020-024, 026, 910);
Neurology (040, 042043, 048, 052-053, 055057); Obstetrics/delivery
(540-542, 560);
Oncology (041, 240,
281, 343, 382, 461, 500,
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530, 690-694); Open
heart surgery (160-163);
Ophthalmologic surgery
(070, 073);
Ophthalmology (080,
082); Orthopedics (340342, 346-347, 349;
Orthopedic surgery
(301-305, 308-310, 312317, 320-321); Other
obstetrics (544, 546,
561, 563-566);
Otolaryngology (111);
Psychiatry (759, 770,
773-776); Rehabilitation
(860); Rheumatology
(351); Transplant
surgery (001, 003);
Urological surgery (440447, 480-483); Urology
(465, 501)
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